PATENT CLAIM ANALYSIS

Application Number: 16146762
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.

Claim (Index 143):
A method of treating a human patient who has had a Fontan procedure for improving the patient's exercise capacity, wherein the human patient is in need of treatment to improve the patient's exercise capacity, the method comprising\n administering to the human patient who has undergone the Fontan procedure an effective amount of udenafil, or a pharmaceutically acceptable salt thereof, to improve the patient's exercise capacity.

Metadata:
- Claim Count in Document: 287.0
- Percentile: 97.0
- Lexical Diversity: 1.04
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15887523', '14788211', '14079548', '15671653', '14442711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.713402659695044
- 35 USC 102 Novelty (BERT): 0.6659707961560525
- Combined Prediction Score: 0.7086594733411449
- Mean Citation Score: 425.65413
- Max Citation Score: 788.03906
- Similarity Product: 615.8201482377826

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test